Table 2.

Anti-HCV and ALT Profiles During Off-Therapy Follow-up in Relation to HCV-RNA Behavior in 114 Patients Cured of Acute Leukemia

Serum HCV-RNANo. of PatientsAnti-HCV During Follow-upALT
End of TreatmentEnd of Follow-upAlways NegativeAlways PositiveSeroconversionSeroreversionPersistently High or Fluctuating (%)Normalized (%)
Negative Negative 47 40 7 (15) 40 (85) 
Positive Positive 40 21 22 (55) 18 (45) 
Positive Negative 16 14 2 (12.5) 14 (87.5) 
Negative Positive 2 (25) 6 (75) 
Not tested Negative 
Serum HCV-RNANo. of PatientsAnti-HCV During Follow-upALT
End of TreatmentEnd of Follow-upAlways NegativeAlways PositiveSeroconversionSeroreversionPersistently High or Fluctuating (%)Normalized (%)
Negative Negative 47 40 7 (15) 40 (85) 
Positive Positive 40 21 22 (55) 18 (45) 
Positive Negative 16 14 2 (12.5) 14 (87.5) 
Negative Positive 2 (25) 6 (75) 
Not tested Negative 
Close Modal

or Create an Account

Close Modal
Close Modal